The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice

The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice

Research on CAR T cells has achieved enormous progress in recent years. After the impressive results obtained in relapsed and refractory B-cell acute lymphoblastic leukemia and aggressive B-cell lymphomas, two constructs, tisagenlecleucel and axicabtagene ciloleucel, were approved by FDA. The role o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marco Cerrano, Marco Ruella, Miguel‐Angel Perales, Candida Vitale, Danilo Faraci, Luisa Giaccone, Marta Coscia, Molly Maloy, Miriam Sánchez‐Escamilla, Hesham Elsabah, Afraa M. Fadul, Enrico Maffini, Gianfranco Pittari, Benedetto Bruno
Formato: Revisão
Lenguaje:inglés
Publicado: 2020
Acceso en línea:https://doi.org/10.3389/fimmu.2020.00888
https://www.frontiersin.org/articles/10.3389/fimmu.2020.00888/pdf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doi.org/10.3389/fimmu.2020.00888
https://www.frontiersin.org/articles/10.3389/fimmu.2020.00888/pdf

Ejemplares similares